Effects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma

Experimental Oncology

Volumn 30, Issue 3, 2008, Pages 212-219

  Filip, A ^a   Clichici, S ^a   Muresan, A ^a   Daicoviciu, D ^a   Tatomir, C ^b   Login, C ^a   Dreve, S ^c   Gherman, C ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Oncologic Institute Ion Chiricu   (Romania)

^c NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT OF ISOTOPIC AND MOLECULAR TECHNOLOGIES   (Romania)

Author keywords

Chitosan; Malondialdehyde; MMPs; PDT; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; CHITOSAN; GELATINASE A; GELATINASE B; MALONALDEHYDE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IRRADIATION; LIPID PEROXIDATION; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; RAT; WALKER CARCINOMA; ZYMOGRAPHY;

AMINOLEVULINIC ACID; ANIMALS; ANTICHOLESTEREMIC AGENTS; CARCINOSARCOMA; CHITOSAN; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; LIGHT; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; RATS, WISTAR;

EID: 53649086067     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Dougherty TJ, Corner CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
2. Triesscheijn M, Bass P, Schellens JHM. Photodynamic therapy in oncology. The Oncologist 2006;11:1034-44.
3. Engbrecht BW, Menon C, Kachur A, et al. Photofrinmediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Research 1999;59:4334-42.
4. Nowis D, Makowski M, Stoklosa T, Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005;52: 339-52.
5. Matroule JY, Volanti C, Plette J, NF-kB in photodynamic therapy: Discrepancies of a master regulator. Photochemistry and Photobiology 2006;82: 1241-6.
6. Curran S, Murray GI, Matrix metalloproteinases: molecular aspects of their role in tumor invasion and metastasis. Eur J Cancer 2000;36: 1621-30.
7. Ferrario A, Chantrain K, Von Thiel KF, et al. The matrix metalloproteinase inhibitor Prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 2004;64: 2328-32.
8. Tatar O, Adam A, Shinoda K, et al. Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol 2007;91: 1183-9
9. Calin MA, Gruia MI, Herascu N, Coman T, Photodynamic therapy of Walker tumors by multiple laser irradiation. Photomedicine and Laser Surgery 2005;23:405-9.
10. Qi LF, Xu ZR, Jiang X, et al. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Biorg Med Chem Lett 2005;15: 1397-9.
11. Lee JK, Iim HS, Kim JH, Cytotoxic activity of aminoderivatized cationic chitosan derivatives. Bioorg Med Chem Lett 2002;12:2949-51.
12. Qi L, Xu Z, Chen M, In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan naanoparticles. Eur J Cancer 2007;43: 184-9.
13. Chen WR, liu H, Richey JW, et al. Effect of Different Components of Laser Immunotherapy in Treatment of Metastatic Tumors in Rats. Cancer Research 2002;62:4295-9.
14. Peng Q, Warloe T, Moan J, et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of Photo frin in human tumor xenografts. Cancer Research 2001;61:5824-32.
15. Granelli-Piperno A, Reich E, A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 1978;148:223-34.
16. Conti M, Moran PC, Levillain P, Improved fluorimetric determination of malondialdehyde. Clin Chem 1991;37: 1273-5.
17. Chen WR, Liu H, Nordquist JA, Nordquist RE, Tumour Cell Damage and Leucocyte Infiltration after Laser Immunotherapy Treatment. Lasers in Medical Science 2000;15, 1: 43-8.
18. Chen WR, Jeong SW, Korbelik M, et al. Enhancement of glycated chitosan in laser cancer treatment, Laser Interaction with tissue and cells XV, Edited by Jacques, Steven L Roach, William P, Proceedings of the SPIE 2004;5319:80-6.
19. Chen WR, Korbelik M, Bartels KE, et al. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochemistry and Photobiology 2005;81: 190-5.
20. Ishihara M, Obara K, Nakamura S, et al. Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J Artif Organs 2006;9:8-16.
21. Maeda Y, Kimura Y, Antitumor effects of various lowmolecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr 2004;134 (4): 945-50.
22. Carreno-Gomez B, Duncan R, Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997;148:231- 40.
23. Qi LF, Xu ZR, Li Y, Jiang X, Han XY, In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 2005;11:5136-41.
24. Jeon TI, Hwang SG, Park NG, et al. Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology 2003;187:67-73.
25. Park PJ, Je JY, Kun SK, Free radical scavenging activities of differently deacetylated chitosan using an ESR spectrometer. Carbohydrate Polymers 2004;55: 17-22.
26. Huang R, Mendis E, Kim SK, Factors affecting the free radical scavenging behavior of chitosan sulfate. Int J Biol Macromolec 2005;30:120-7.
27. Je YJ, Kim SK, Reactive oxygen species scavenging activity of aminoderivatezed chitosan with different degree of deacetyiation. Biorganic & Medicinal Chemistry 2006;14: 5989-94.
28. Pazos MDC, Nader HB, Effect of photodynamic therapy on the extracellular matrix and associated components. Braz J Med Bio Res 2007;40: 1025-35.
29. Van Ta Q, Kim MM, Kim SK, Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080) Mar Biotechnol 2006;8: 593-9.
30. Kim MM, Kim SK, Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human derma! fibroblasts. FEBS Lett 2006;15, 580: 2661-6.
31. Rajapakse N, Kim MM, Mendis E, et al. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. Biochim Biophys Acta 2006;1760: 1780-8.
32. Chellat F, Grandjean-Laquerriere A, Le Naour R, et al. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles Biomaterials 2005;26:961-70.